AI-generated content for informational purposes only. Not financial advice. Always do your own research.

About

Tilray Brands (NASDAQ: TLRY) is a global cannabis and consumer packaged goods company operating across cannabis, beverage alcohol, wellness, and distribution segments, with a significant presence in Canada, Europe, and the United States. The company has pursued an aggressive acquisition strategy, building one of the largest cannabis operations in the world while diversifying into craft beer and spirits through purchases of brands like SweetWater Brewing and Montauk Brewing. As an investment, Tilray offers leveraged exposure to potential U.S. federal cannabis legalization and the global expansion of legal marijuana markets, though persistent industry headwinds and dilution remain key risks.

Cannabis Stocks

Tilray Brands is a major cannabis stock and one of the world's largest marijuana companies by revenue, with leading market share in Canadian cannabis sales and a growing international footprint in Europe and the U.S., making it a key holding for investors seeking broad exposure to the global legal cannabis industry.

Penny Stocks

Tilray Brands trades at penny stock valuations after significant share price declines from its highs, representing a speculative opportunity for investors willing to bet on a cannabis industry turnaround and potential U.S. federal legalization at a deeply discounted entry point.

Key Financials TLRY

Price $7.51
Change (1D) +0.27%
Change (30D) -16.83%
Change (60D) -27.09%
Change (90D) -52.47%
Change (180D) +66.89%
Change (1Y) -20.95%
Change (5Y) -98.23%
P/E Ratio 17.88
EPS (TTM) $0.42
52-Week Range $3.50 โ€” $23.20
50-Day MA $9.00
Volume 2.93M

Data updated Feb 15 ยท Source: Twelve Data

3.7 2 reviews

AI Reviews

๐Ÿค–
3.3 /5

Tilray Brands is the world's largest cannabis company by revenue, with diversified operations spanning cannabis, craft beer, spirits, and wellness products across multiple continents. The diversification strategy under CEO Irwin Simon has positioned Tilray for potential U.S. federal legalization, though execution has been uneven.

The bull case centers on Tilray's market leadership, international footprint, and a surprisingly reasonable P/E of 17.88 with positive EPS of $0.42"rare profitability in cannabis. The 180-day gain of 66.89% from its $3.50 low shows significant momentum potential when sentiment shifts.

However, the bear case is substantial. The stock has lost 98.23% over five years, reflecting massive shareholder dilution and persistent cash burn historically. The 90-day decline of 52.47% signals renewed selling pressure, and the stock trades well below its 50-day moving average of $9.00. U.S. legalization timelines remain uncertain, and competition intensifies.

Tilray offers high-risk speculative exposure to cannabis with better fundamentals than most peers, but the long-term destruction of shareholder value demands caution. Position sizing is critical here.

Category Ratings

Cannabis Stocks
3.4
Penny Stocks
3.2
Feb 15, 2026
AI-Generated Review Generated via Anthropic API. This is an automated evaluation, not a consumer review. Learn more
๐Ÿค–
4.1 /5

Tilray Brands (TLRY) presents a unique profile within the cannabis sector, particularly given the data indicating profitability"a rarity among its peers. With a P/E ratio of 18.64 and positive earnings per share of $0.42, the company appears fundamentally healthier than many competitors that struggle with cash burn. Its diversification strategy, blending core cannabis operations with a growing portfolio of craft beverage brands, offers a hedge against regulatory delays.

However, the investment carries significant risk. The stock is currently trading well below its 50-day moving average of $9.02 and has retreated sharply from a 52-week high of $23.20, signaling bearish technical momentum. While the valuation is attractive for a growth-oriented company, the volatility remains high. For investors seeking exposure to the cannabis industry, Tilray offers a compelling, albeit speculative, mix of tangible earnings and global scale, provided one can tolerate the sector's inherent instability.

Category Ratings

Cannabis Stocks
4.2
Penny Stocks
3.9
Feb 11, 2026
AI-Generated Review Generated via Google API. This is an automated evaluation, not a consumer review. Learn more
Tilray Brands Screenshot

Added: Feb 10, 2026

tilray.com